Blockchain

The Tie Launches Polkadot Ecosystem Dashboard on The Tie Terminal

Boston, Mass, September 12th, 2024, Chainwire

 

New Dashboard Provides Institutional Clients with In-Depth Insights into the Polkadot Ecosystem

The Tie, a leading provider of market data, news, and analytics for digital assets, launches the Polkadot Ecosystem Dashboard enabling institutional clients to access a comprehensive suite of analytics for Polkadot-based assets.

The Polkadot Ecosystem Dashboard offers a deep dive into essential metrics and insights, enabling users to understand key aspects of the network’s performance and usage. By accessing Polkadot blockchain data via The Tie Terminal, investors and traders can make more informed decisions, enhance their understanding of assets and projects within the ecosystem, and gain valuable insights into one of the most dynamic ecosystems in the digital asset space.

“We’re excited to launch the Polkadot Ecosystem Dashboard, providing our institutional clients with powerful tools to analyze and understand the rapidly evolving Polkadot ecosystem,” said Joshua Frank, Co-Founder & CEO of The Tie. “This addition to The Tie Terminal reflects our commitment to delivering the most comprehensive insights, enabling informed decision-making in institutional crypto.”

The dashboard includes account and native token metrics, allowing users to track the growth of the ecosystem by monitoring new, active, and cumulative account metrics over time for each parachain. This feature provides a clear view of user adoption and engagement, while detailed data on the total, staked, and circulating supply units of parachain tokens reflect community growth and interest. Additionally, information on the number of native token holders and price trends across the ecosystem offers further context for analyzing network performance.

Users can also access an overview of transaction metrics, including the volume of native tokens transferred within parachains over time. Transactions are categorized into signed and unsigned types, providing insights into network activity and user behavior. The dashboard tracks transaction fees in both native tokens and USD and displays transaction counts for parachains with Ethereum Virtual Machine (EVM) compatibility, such as Moonbeam and Astar. Additionally, the dashboard monitors Cross-Consensus Messaging (XCM) transactions, offering a comprehensive understanding of cross-chain interactions and interoperability within the Polkadot network.

The Total Value Locked (TVL) metrics provide a detailed analysis of the value locked across parachains, updated every 12 hours. This includes categories such as staking, governance tokens, and liquid staking. A treemap component offers a visual representation of the latest TVL metrics, presenting a high-level perspective of the ecosystem’s value and activity.

The dashboard also features the latest XCM activity metrics, including data on XCM transfers, messages, open channels, and connected parachains, providing a thorough overview of Polkadot’s cross-chain messaging dynamics. The screener function allows users to track ecosystem coins and events, enabling them to filter the dashboard according to specific coins, watchlists, or sectors. This feature ensures that institutional clients remain updated on critical events within the Polkadot ecosystem, helping them stay ahead of significant developments.

The Polkadot Ecosystem Dashboard is designed to give users a holistic view of the network’s performance, making it easier to track developments, analyze trends, and explore the diverse projects within the Polkadot ecosystem. With this addition, The Tie Terminal continues to be an essential tool for institutional clients seeking comprehensive and actionable data in the digital asset space.

The Polkadot Ecosystem Dashboard is now available under the “Presets” section in the Dashboard Selection screen on The Tie Terminal. For more information, readers can visit The Tie’s website.

About The Tie

The Tie is the leading provider of information services for digital assets operating across three core verticals: Institutional, Data Redistribution, and Corporate Access. On the Institutional side, The Tie’s core offering – The Tie Terminal is the fastest and most comprehensive workstation for institutional digital asset investors. The Tie’s institutional clients include hundreds of the leading traditional and crypto-native hedge funds, VCs, market makers, asset managers, banks, and other institutional market participants.

The Tie’s Redistribution business syndicates data feeds to dozens of leading platforms including FalconX, BitMEX, Real Vision, Broadridge, and Cointelegraph. The Tie’s corporate access business provides direct connectivity between institutions and token issuers through a series of industry leading conferences and events – including our flagship event, The Bridge hosted in 2023 with The New York Stock Exchange.

About Polkadot

Polkadot is the powerful, secure core of Web3, providing a shared foundation that unites some of the world’s most transformative apps and blockchains. Polkadot offers advanced modular architecture that allows devs to easily design and build their own specialized blockchain projects, pooled security that ensures the same high standard for secure block production across all connected chains and apps connected to it, and robust governance that ensures a transparent system where everyone has say in shaping the blockchain ecosystem for growth and sustainability. With Polkadot, users are not just a participant, they are a co-creator with the power to shape its future.

 

Contact

Jonathan Duran
jonathan@distractive.xyz

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

2024-09-19T13:00:00Z

Strategic partnership aims to further develop Cube’s award-winning AI guided platform for Software as a Service (SaaS) for the private sector and large healthcare systems and diagnostic to support clinicians and patients in making informed therapeutic decisions from early detection to personalized treatment and disease monitoring, for improved health outcomes

AMSTERDAM, Sept. 19, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) PersonalAIze and RenovaroCube are proud to announce a strategic partnership to develop, validate, and commercialize Cube’s AI-driven, multi-omic platform for early detection of cancer and other diseases. This strategic partnership aims to provide services to many AI companies and healthcare systems while also creating the next generation of medical diagnostics through cutting-edge AI by driving greater accuracy, transparency, and trust in healthcare solutions.

Prof. Mark Hoogendoorn, Co-CEO and Co-Founder PersonalAIze: "The strategic partnership between PersonalAIze and Cube has the potential to provide a transformative leap in healthcare diagnostics, uniting cutting-edge AI with trusted, high-performance capabilities and industry related in-depth expertise.”

Frank van Asch, Founder and CTO of RenovaroCube,” Together, we are pioneering a future where healthcare outcomes are improved by training models for multiple decisions through the entire health journey, ensuring the right accuracy for therapeutic decisions in every disease stage.”

The first phase of the collaboration focuses on establishing a strong foundation for the partnership, with PersonalAIze providing critical expertise in the integration of AI into healthcare. It will enhance existing collaborations with Academic and corporate partners and create new ones to build an eco-system to help develop and bring to the market a cutting-edge SaaS model and the next generation highly accurate diagnostics, starting with cancer.

Prof Sandjai Buhlai, Co-CEO and Co-Founder PersonalAIze: “This collaboration signals a bold step forward in utilizing the full potential of AI potentially to help revolutionize early-stage medical interventions and diagnosis at the earliest stage of cancer before imaging has been able to detect the tumors.”

Key contributions from PersonalAIze include:

  • Ethical AI: Ensuring the AI models are free from harmful biases and trained to support fairness and inclusivity in medical diagnostics.
  • Legal Guidance: Providing expert advice on legal responsibilities tied to AI outputs, including issues of AI accountability and potential liability.
  • Regulatory Compliance: Assisting in navigating existing and emerging regulations such as NEN, ISO, GDPR, and the AI Act, ensuring the platform adheres to all relevant healthcare regulations and clinical guidelines.
  • Medical and Diagnostic Input: Offering support in clinical validation in collaboration with medical scientists to ensure the AI is reliable and effective in real-world medical environments.
  • Explainable AI: Developing AI models that are transparent, fostering trust and confidence from both healthcare providers and patients.

Key Resources and Support from PersonalAIze
As part of the collaboration, PersonalAIze will contribute:

  • Expert Personnel: Including a Principal Investigator (PI) to lead clinical AI efforts, a project manager to coordinate the collaboration and a strategic advisor to oversee the scientific strategy and execution.
  • Research and Talent Capacity: Leveraging academic partnerships to ensure access to cutting-edge research and innovation and facilitating talent scouting to support the project’s development.
  • Academic Spin-Out Opportunities: Supporting the commercialization of academic research through potential spin-out ventures related to AI diagnostics.
  • Co-Development of AI Platform: Jointly developing a science-driven, evidence-based AI platform that meets rigorous clinical and regulatory standards.
  • Ongoing Research and Publications: Contributing to the body of research through support with peer-reviewed publications in collaboration with clinical experts that will help build trust within the medical community and among regulatory bodies.
  • Architecture and Strategy Guidance: Continuously advising on the platform’s architecture and strategic direction, ensuring it stays aligned with the latest industry trends and scientific advancements.
  • Trusted AI: Developing a trustworthy, explainable AI platform that inspires confidence among healthcare providers and patients through clear and transparent decision-making processes.

About PersonalAIze
PersonalAIze focuses on building solutions that improve healthcare by leveraging state-of-the-art AI techniques. It has been founded by four experienced professors bringing together decades of research experience in AI and healthcare with the aim to bring the latest scientific AI developments into healthcare practice faster. PersonalAIze does this through both consultancy and product development and targets clinical decision-making systems as well as improvement of health care operations such as capacity planning.

About Renovaro
Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in disease agnostic decision support.

Forward-Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

For media inquiries, please contact: karen@renovarocube.com

Source: Renovaro Inc.


GlobeNewsWire News

Recent Comments